Email this article Prevalence and survival of patients with malignant tumors of the thymus gland (C37) (population study at the federal district level)
- Authors: Merabishvili V.M.1
-
Affiliations:
- N. N. Petrov National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation
- Issue: Vol 4, No 1 (2022)
- Pages: 36-45
- Section: Biomedical Sciences
- URL: https://journals.rcsi.science/PharmForm/article/view/105884
- DOI: https://doi.org/10.17816/phf105884
- ID: 105884
Cite item
Full Text
Abstract
We have attempted to establish the patterns of occurrence of malignant neoplasms of the thymus gland (C37) and get some idea of the effectiveness of its treatment at the population level. This opportunity was presented to us in connection with the development of the Cancer Registry database at the level of the Northwestern Federal District of the Russian Federation, consisting of more than 1 million 350 thousand patients records with a population of more than 13 million people.
As a result of the study, based on the database of the newly created Population-based Cancer Registry of the Northwestern Federal District, to determine the prevalence, primary mortality and survival of patients with malignant neoplasms of the thymus gland (C34), taking into account gender, age characteristics and survival of patients. At the international level, we propose to divide the combined heading С37, 38 and separate С37.
The material for the study was the database of the Population-based Cancer Registry with more than 1 million 350 thousand observations; standard research methods recommended by the International Association of Cancer Registries.
The conducted research has shown the possibility to assess the prevalence and effectiveness of anticancer measures for rare malignant neoplasms. The specific weight of malignant neoplasms of the thymus gland (C37) among all tumors in the Northwestern Federal District is 0.02%, 5 times less than the occurrence of malignant neoplasms of the heart (C38). Attention is drawn to the fact that in recent years the accounting of this group of tumors has significantly improved in the Northwestern Federal District. There were no sharp differences in the structure of the male and female population in the values of registered cases of the disease among people younger and older than 60 years.
Full Text
##article.viewOnOriginalSite##About the authors
Vakhtang M. Merabishvili
N. N. Petrov National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation
Author for correspondence.
Email: MVM@niioncologii.ru
ORCID iD: 0000-0002-1521-455X
SPIN-code: 5705-6327
Doctor of Medicine (MD), Professor, Chief of the the Oncological Statistics Scientific Laboratory, Chairman of the Scientific-Methodological Council on Development of Information Systems of Cancer Control of the Northwestern Federal District, Head of the Population-based Cancer Registry of the Northwestern Federal District of the Russian Federation
Russian Federation, 68 Leningradskaya street, St. Petersburg, 197758References
- Parkin D. M., Whelan S. L., Ferlay J., et al. Cancer Incidence in Five Continents, Vol. VII. IARC Scientific Publication No. 143. Lyon: IARC; 1997.
- VOZ. Mezhdunarodnaja statisticheskaja klassifikacija boleznej i problem, svjazannyh so zdorov'em (MKB-10) v 3 tomah. Zheneva, 1995. 698 p. (In Russ.).
- Merabishvili V. M., ed. Spravochnik sopostavlenija kodov MKB-9 i MKB-10 peresmotrov po klassu novoobrazovanij. Vtoroe izdanie utochnennoe i dopolnennoe. Saint Petersburg, 1998. 91 p. (In Russ.).
- Merabishvili V. M. Malignant cardiac tumors – rare, but dangerous tumors (based on the data obtained in the Northwestern Federal District of Russia). Formuly Farmacii = Pharmacy Formulas. 2020;2(3):30-39. (In Russ.).
- Merabishvili V. M., Merabishvili E. N. The Prevalence of Malignant Tumors of the Eye and Adnexa (C69). Oftal'mologija = Ophthalmology in Russia. 2020;17(3):495–501. (In Russ.).
- Merabishvili V. M., Merabishvili E. N. Age-related features of the prevalence and survival of patients with malignant tumors of the eye and its adnexa (c69) with taking into account the localization and histological structure: population study. Uspehi gerontologii = Adv Gerontol. 2019;32(3):301-310. (In Russ.).
- Gusenkova L., Merabishvili V., Lashin V., et al. Cancer incidence in Russian Federation, Karelia // In: Bray F., Colombet M., Mery L., et al., eds. Cancer Incidence in Five Continents, Vol. XI. IARC Scientific Publication No. 166. Lyon: IARC; 2021. P. 886-887, 1013-1410.
- Vazhenin A., Domozhirova A., Aksenova I., et al. Cancer incidence in Russian Federation, Chelyabinsk // In: Bray F., Colombet M., Mery L., et al., eds. Cancer Incidence in Five Continents, Vol. XI. IARC Scientific Publication No. 166. Lyon: IARC; 2021. P. 884-885, 1013-1410.
- Merabishvili V. M. The index accuracy - the most important criterion of an objective assessment of activity of oncological service for all localizations of malignant tumors, irrespective of level of lethality of patients. Voprosy onkologii = Problems in oncology. 2019;65(4):510-515. (In Russ.).
- Merabishvili V. M. Analytical indicators of observation. the year-by-year lethality of patients at each year. Voprosy onkologii = Problems in oncology. 2021;67(1):44-50. (In Russ.).
- Beljaev A. M., Chepik O. F., Artem'eva A. S., et al., eds. Mezhdunarodnaja klassifikacija boleznej – onkologija (MKB-O), 3 izdanie, 1 peresmotr. Sost. Je. Fritc, K. Persi, Je. Dzhek, K. Shanmugaratnam, L. Sobin, D.M. Parkin, Sh. Uilan. Saint Petersburg: Voprosy onkologii; 2017. 352 p. (In Russ.).
- Berezkin D. P. Metody izuchenija vyzhivaemosti onkologicheskih bol'nyh. Metodicheskie rekomendacii. Leningrad, 1982. 24 p. (In Russ.).
- Merabishvili V. M., Shcherbuk Yu. A., eds. Survival of cancer patients. 2nd issue. Part I. Saint Petersburg: KOSTA; 2011. 330 p. (In Russ.).
- Merabishvili V. M., Shcherbuk Yu. A., eds. Survival of cancer patients. 2nd issue. Part II. Saint Petersburg: KOSTA; 2011. 408 p. (In Russ.).
- Merabishvili V. M., Belyaev A. M., Shcherbakov A. M., eds. Malignant tumors in the North-West Federal Region of Russia (morbidity, mortality, prevalence rate, survival). Express-information. 5th issue. Guidelines for physicians. Saint Petersburg: T8 Print; 2020. 236 p. (In Russ.).
- Napalkov N. P., Berezkin D.P. Principy i metody izucheniya vyzhivaemosti onkologicheskih bol'nyh. Voprosy onkologii = Problems in oncology. 1982;(8):10-13. (In Russ.).
- Kaprin A. D., Starinsky V. V., Shakhzadova A. O., eds. State of oncological care in Russia in 2020. Moscow: P.A. Herzen Moscow State Medical Research Institute - branch of the NMRRC of the Ministry of Health of the Russian Federation; 2020. 239 p. (In Russ.).
- Berrino F., Capocaccia R., Coleman M.P., et al., eds. Survival of cancer patients in Europe: the EUROCARE-2 study (IARC Scientific Publication No. 151). Lyon: International Agency for Research on Cancer, 1999.
- Berrino F., Capocaccia R., Esteve J., et al. EUROCARE-3: the survival of cancer patients diagnosed in Europe during 1990-94. Ann Oncol. 2003;14(Suppl. 5):1-155.
- Berrino F., Sant M., Verdecchia V., et al., eds. Survival of cancer patients in Europe: the EUROCARE Study (IARC Scientific Publication No. 132). Lyon: International Agency for Research on Cancer, 1995.
- Capocaccia R., Gavin A., Hakulinen T., et al. Survival of cancer patients in Europe, 1995-2002. The EUROCARE-4 study. Eur J Cancer. 2009;45.
- De Angelis R., Sant M., Coleman M., et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5 – a population-based study. Lancet Oncol. 2014;15:23-34. http://dx.doi.org/10.1016/S1470-2045(13)70546-1.
Supplementary files
